Health Evidence Review Commission's Value-Based Benefits Subcommittee
Total Page:16
File Type:pdf, Size:1020Kb
Health Evidence Review Commission's Value-based Benefits Subcommittee October 4, 2018 8:30 AM - 1:00 PM Clackamas Community College Wilsonville Training Center, Room 111-112 29373 SW Town Center Loop E, Wilsonville, Oregon, 97070 Section 1.0 Call to Order AGENDA VALUE-BASED BENEFITS SUBCOMMITTEE October 4, 2018 8:30am - 1:00pm Clackamas Community College 29373 SW Town Center Loop E, Wilsonville Training Center, Rooms 111-112 Wilsonville, Oregon A working lunch will be served at approximately 12:00 PM All times are approximate I. Call to Order, Roll Call, Approval of Minutes – Kevin Olson 8:30 AM II. Staff report – Ariel Smits, Cat Livingston, Darren Coffman 8:35 AM III. Straightforward/Consent agenda – Ariel Smits 8:45 AM A. Consent table B. S86 code review C. Coding issues for gender dysphoria IV. Previous discussion items 8:50 AM A. F39 Unspecified Mood Disorder B. Brow ptosis repair C. Blepharoplasty V. 2020 Biennial Review 9:30 AM A. Neonatal circumcision VI. New discussion items 10:00 AM A. Medical indications for circumcision B. Items carried over from August VBBS meeting A. Postpartum depression screening B. Cardiac MRI C. Allergy testing for eczema D. MRI Guided Focused Ultrasound (MRgFUS) E. Human donor breast milk F. SI joint dysfunction prioritization G. Testosterone hypofunction H. iStent for open angle glaucoma I. Humeral osteotomy for recurrent shoulder dislocation VII. Coverage guidances 12:00 PM A. CarioMEMs Health Evidence Review Commission (503) 373-1985 VIII. Public comment 12:55 PM IX. Adjournment – Kevin Olson 1:00 PM Health Evidence Review Commission (503) 373-1985 Value-based Benefits Subcommittee Recommendations Summary For Presentation to: Health Evidence Review Commission on August 9, 2018 For specific coding recommendations and guideline wording, please see the text of the 8/9/2018 VbBS minutes. RECOMMENDED CODE MOVEMENT (effective 10/1/2018 unless otherwise noted) • Add neuropsychological testing done by computer or technician to various covered mental health lines • Add 2019 ICD-10 codes to various covered and uncovered lines • Add acne fulminans to a covered line (effective January 1, 2019) • Add procedure codes for inserting drug eluting stents into coronary arteries to several heart disease lines • Add the procedure code for Eustachian tube inflation to an uncovered line • Makes the PET scan codes diagnostic and remove from lines; make the PET scan guideline into a diagnostic guideline • Add the code for prediabetes to Line 3 and recommend it be removed from the Diagnostic Procedures File. Add a series of temporary codes for the delivery of the Diabetes Prevention Program to Line 3. (effective January 1, 2019) • Move several developmental and speech delay codes to the dysfunction lines • Add the procedure code for nasal vestibular wall stenosis implants to an uncovered line • Add the procedure code for computer assisted musculoskeletal surgery to an uncovered line • Add procedure codes for insertion of buprenorphine implants to the substance disorder line (effective January 1, 2019) • Add the generic diagnosis code that can be used for adult human growth hormone deficiency to an uncovered line with a new coding specification that it is only on the uncovered line for that specific diagnosis (effective January 1, 2019) • Various straightforward coding and guideline note changes. RECOMMENDED GUIDELINE CHANGES (effective 10/1/2018 unless otherwise noted) • Edit the guideline for chemodenervation with botulinum toxin for chronic migraine to require medication overuse to be addressed and to modify the requirements for pharmacotherapies • Edit the severe inflammatory skin disease line to update the step therapy requirements for atopic dermatitis • Edit the guideline note on biomarker tests of cancer tissue • Add a new diagnostic guideline note on urine drug testing • Edit the guideline for breast reconstruction after mastectomy to indicate that revision surgery is only covered for medical, not cosmetic, indications • Delete the guidelines regarding implantable buprenorphine and enzyme replacement therapy (effective January 1, 2019) • Edit the human growth hormone guideline to remove the restrictions on types of childhood diseases that are covered for treatment (effective January 1, 2019) • Add a new guideline to clarify coverage for the treatment of prediabetes with the Diabetes Prevention Program when delivered by CDC-certified programs (effective January 1, 2019) Value-based Benefits Subcommittee Summary Recommendations, 8/9/2018 • Edit the guideline on overweight and obesity to make reference to the new Diabetes Prevention Program guideline (effective January 1, 2019) BIENNIAL REVIEW CHANGES (effective 1/1/2020) • Create a new line for severe acne which will be in the funded region, with a new guideline • Reorganize the burn lines from 4 lines into 3 VALUE-BASED BENEFITS SUBCOMMITTEE Clackamas Community College Wilsonville Training Center, Rooms 111-112 Wilsonville, Oregon August 9, 2018 8:00 AM – 1:00 PM Members Present: Kevin Olson, MD, Chair; Mark Gibson; Holly Jo Hodges, MD; Vern Saboe, DC; Gary Allen, DMD; Adriane Irwin, PharmD Members Absent: Susan Williams, MD Staff Present: Darren Coffman; Ariel Smits, MD, MPH; Cat Livingston, MD, MPH; Wally Shaffer, MD; Daphne Peck; Mark Altenhofen Also Attending: Napua Catriz (OHA); Adam Obley, MD (Center for Evidence-based Medicine); Dr. Julie Dhossche and Dr. Tracy Funk (OHSU); Carolyn Concion, NP; Rob Twillman (Academy of Integrative Pain Medicine); Karen Yeargain; Edith Agoff; Ginevra Liptan MD (Frida Center for Fibromyalgia); Allan Chino, PhD; Windy Sinclair; Shane Sinclair; Amara McCarthy; Kim Martin Thanislaus; Karl Probst; Patrick Starnes; Steven Hix; Zane Six; Laura A Dolph; Rick Schmitt; Amanda Siebe (Disables Americans for Change); Helen Turner; Kelly Howard; Leonard Ramey; Laura Stallard; BJ Cavnor (One in Four); Margaret Olmon and Laura Jeffcoat (Abbvie); Becky Harison (BioMartin); Deena Loughany and Jay Wurschev (DHS Child Welfare); Sara Gore (Millennium); David Balham (Genentech); David Barba. Roll Call/Minutes Approval/Staff Report The meeting was called to order at 8:00 am and roll was called. Minutes from the May 17, 2018 VbBS meeting were reviewed and approved. Staff noted that the minutes included in the meeting packet had some typos in the line placements for the HCPCS “C” code issue; these line numbers have been corrected. Smits brought the errata document to the attention of the subcommittee members. There were no comments or discussion. Topic: Straightforward/Consent Agenda Discussion: There was no discussion about the consent agenda items. Recommended Actions: 1) Add ICD-10 Z45.42 (Encounter for adjustment and management of neuropacemaker) to line 250 PARKINSON'S DISEASE 2) Remove ICD-10 N43.4 series (Spermatocele of epididymis) from line 327 FUNCTIONAL AND MECHANICAL DISORDERS OF THE GENITOURINARY SYSTEM INCLUDING BLADDER OUTLET OBSTRUCTION 3) Add G0270-G0271 (Medical nutrition therapy) to line 320 OBESITY IN ADULTS AND CHILDREN; OVERWEIGHT STATUS IN ADULTS WITH CARDIOVASCULAR RISK FACTORS Value-based Benefits Subcommittee Minutes, 8/9/2018 Page 3 4) Add H0023 (Behavioral health outreach service (planned approach to reach a targeted population)) to line 4 SUBSTANCE USE DISORDER 5) Add N18.5 (Chronic kidney disease, stage 5) to line 59 END STAGE RENAL DISEASE 1) Remove N18.5 from line 339 CHRONIC KIDNEY DISEASE 6) Add 50389 (Removal of nephrostomy tube, requiring fluoroscopic guidance), 50432 (Placement of nephrostomy catheter, percutaneous), 50435 (Exchange nephrostomy catheter, percutaneous) and 50695 (Placement of ureteral stent, percutaneous) to line 25 VESICOURETERAL REFLUX 7) Add 11004 (Debridement of skin, subcutaneous tissue, muscle and fascia for necrotizing soft tissue infection; external genitalia and perineum), 11006 (Debridement of skin, subcutaneous tissue, muscle and fascia for necrotizing soft tissue infection; external genitalia, perineum and abdominal wall, with or without fascial closure), 11042 (Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less), 13131-1313 (Repair, complex, forehead, cheeks, chin, mouth, neck, axillae, genitalia), 15004-15005 (Surgical preparation or creation of recipient site by excision of open wounds, burn eschar, or scar) and 55150 (Resection of scrotum) to line 47 DEEP ABSCESSES, INCLUDING APPENDICITIS AND PERIORBITAL ABSCESS 8) Add 57420-57421 (Colposcopy of the entire vagina, with cervix if present) to line 25 DYSPLASIA OF CERVIX AND CERVICAL CARCINOMA IN SITU, CERVICAL CONDYLOMA 9) Add 49020 (Drainage of peritoneal abscess or localized peritonitis, exclusive of appendiceal abscess, open), 49322 (Laparoscopy, surgical; with aspiration of cavity or cyst (eg, ovarian cyst)) and 49406-49407 (Image-guided fluid collection drainage by catheter) to line 51 ACUTE PELVIC INFLAMMATORY DISEASE 10) Revise Guideline Note 148 as shown in Appendix A 11) Modify GN173 as shown in Appendix A MOTION: To approve the recommendations stated in the consent agenda. CARRIES 6-0. Topic: Behavioral Health Advisory Panel report Discussion: Smits reviewed the summary documents. There was no discussion regarding the general recommendations. There was discussion regarding the recommendations about a guideline for ICD-10 F39 (Unspecified mood [affective] disorder). Hodges felt that adopting the proposed guideline would make the exceptions process more streamlined. Gibson felt that the relative lack of use for more than a few visits did not require the adoption